Abacus Planning Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,619
Closed -$206K 194
2022
Q4
$206K Buy
+2,619
New +$196K 0.06% 164
2022
Q3
Sell
-3,203
Closed -$257K 189
2022
Q2
$257K Sell
3,203
-400
-11% -$31.3K 0.08% 147
2022
Q1
$273K Sell
3,603
-15
-0.4% -$1.19K 0.07% 163
2021
Q4
$309K Buy
3,618
+380
+12% +$29.7K 0.08% 152
2021
Q3
$245K Hold
3,238
0.08% 165
2021
Q2
$263K Buy
3,238
+325
+11% +$26.6K 0.08% 156
2021
Q1
$230K Hold
2,913
0.07% 164
2020
Q4
$249K Hold
2,913
0.08% 145
2020
Q3
$225K Hold
2,913
0.08% 139
2020
Q2
$213K Buy
+2,913
New +$207K 0.09% 140
2020
Q1
Sell
-2,997
Closed -$206K 166
2019
Q4
$206K Hold
2,997
0.09% 159
2019
Q3
$220K Buy
+2,997
New +$217K 0.11% 147

Other funds holding CL

Abacus Planning Group's CL Position: Q1 2023 in Review

Abacus Planning Group sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 2,619 shares — an estimated $206K sold.

Abacus Planning Group first reported a position in CL in Q3 2019 and held it in 12 quarters. The position peaked at $309K in Q4 2021. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Abacus Planning Group reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Abacus Planning Group sold 2,619 Colgate-Palmolive shares in Q1 2023, an estimated $206K.
  • Abacus Planning Group first reported a position in Colgate-Palmolive in Q3 2019 and held it in 12 quarters.
  • Abacus Planning Group's Colgate-Palmolive position peaked at $309K in Q4 2021.
  • 1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Abacus Planning Group's 13F filing for Q1 2023, filed 18 Apr 2023.